Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
12.08
+0.70 (6.15%)
Mar 9, 2026, 3:32 PM EDT - Market open
Company Description
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton.
It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted.
Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Ekso Bionics Holdings, Inc.
| Country | United States |
| Founded | 2005 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 55 |
| CEO | Scott Davis |
Contact Details
Address: 101 Glacier Point, Suite A San Rafael, California 94901 United States | |
| Phone | 510 984 1761 |
| Website | eksobionics.com |
Stock Details
| Ticker Symbol | EKSO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001549084 |
| CUSIP Number | 282644400 |
| ISIN Number | US2826444000 |
| SIC Code | 3569 |
Key Executives
| Name | Position |
|---|---|
| Scott G. Davis | Chief Executive Officer and Director |
| Jerome Wong | Chief Financial Officer and Corporate Secretary |
| Jason C. Jones | Chief Operating Officer |
| Lisa Bentley | Head of Marketing |
| Ann Cookson | Human Resources Director |
| Stephan Aderhold | Senior Vice President and GM of EMEA |
| Katherine Strausser | Principal Controls Engineer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 23, 2026 | 10-K | Annual Report |
| Feb 17, 2026 | SCHEDULE 13G/A | Filing |
| Feb 17, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 17, 2026 | 8-K | Current Report |
| Jan 29, 2026 | SCHEDULE 13G/A | Filing |
| Jan 22, 2026 | 8-K | Current Report |
| Jan 8, 2026 | SCHEDULE 13G | Filing |
| Dec 29, 2025 | 8-K | Current Report |
| Nov 7, 2025 | 8-K | Current Report |
| Oct 30, 2025 | 8-K | Current Report |